Cargando…
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
OBJECTIVE: This study investigated early, real‐world outcomes with cenobamate (CNB) in a large series of patients with highly drug‐resistant epilepsy within a Spanish Expanded Access Program (EAP). METHOD: This was a multicenter, retrospective, observational study in 14 hospitals. Inclusion criteria...
Autores principales: | Villanueva, Vicente, Santos‐Carrasco, Daniel, Cabezudo‐García, Pablo, Gómez‐Ibáñez, Asier, Garcés, Mercedes, Serrano‐Castro, Pedro, Castro‐Vilanova, Maria D., Sayas, Débora, Lopez‐Gonzalez, Francisco J., Rodríguez‐Osorio, Xiana, Torres‐Gaona, Gustavo, Saiz‐Diaz, Rosa A., Hampel, Kevin G., Martinez‐Ferri, Meritxell, Aguilar‐Amat, Maria J., Mercedes‐Alvarez, Blanca, García‐Morales, Vanessa, del Villar‐Igea, Ana, Massot‐Tarrús, Andreu, Rodríguez‐Uranga, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472366/ https://www.ncbi.nlm.nih.gov/pubmed/37149853 http://dx.doi.org/10.1002/epi4.12757 |
Ejemplares similares
-
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies
por: Serrano-Castro, Pedro J., et al.
Publicado: (2023) -
Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy
por: Massot-Tarrús, Andreu, et al.
Publicado: (2022) -
Onset of efficacy and adverse events during Cenobamate titration period
por: Steinhoff, Bernhard J., et al.
Publicado: (2022) -
Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study
por: Massot-Tarrús, Andreu, et al.
Publicado: (2022) -
Is Cenobamate the Breakthrough We Have Been Wishing for?
por: Specchio, Nicola, et al.
Publicado: (2021)